Search

181 Result(s)
Sort by

Professor Baumgart

Professor Baumgart

After being diagnosed with diabetes, Eric’s unique bonds with Peetey and Jake meant they could run miles across the Idaho wilderness. Learn more here.
COVID-19 RCV thank you

COVID-19 RCV thank you

A big thank you to all doctors, all nurses and all others working in the healthcare sector from the employees of BI Regional Centre Vienna. Read more here!
Our Contribution

Our Contribution

Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come. Click here to find out more.
Innovation Needs Transparency

Innovation Needs Transparency

At Boehringer Ingelheim, we prioritise the establishment and maintenance of public trust. Transparency is therefore a key pillar of our corporate culture.
COVID-19 Jordan medicine donations

COVID-19 Jordan medicine donations

Boehringer Ingelheim donates medicines in Jordan to support patients with chronic conditions. Click here to find out more about this support.
COVID-19 Volunteering in Saudi Arabia

COVID-19 Volunteering in Saudi Arabia

Hisham Gweda, took a bold step and joined the Saudi Red Crescent Authority’s Active Ready Health Volunteers Program. Click here to find out and learn more.
COVID-19 Once a nurse always a nurse

COVID-19 Once a nurse always a nurse

Colleagues Anne Hunstad and Maarten van Helvoirt, both educated nurses, support the health care workers during the COVID-19 pandemic. Learn more.
1988-2015

1988-2015

Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. Learn more here.
The Angels Initiative – F.A.S.T.

The Angels Initiative – F.A.S.T.

Recognise the symptoms of stroke and seek immediate medical help to improve outcomes. Click here to learn more and find out more information.
Patient Centricity

Patient Centricity

At Boehringer Ingelheim, we put patients first in everything we do. Click here to learn more about patient centricity at Boehringer Ingelheim.
Our Responsibility

Our Responsibility

Our responsibility here at Boehringer Ingelheim to our patients is by serving people through research into diseases with unmet needs. Learn more here.
NexGard Spectra launched in China

NexGard Spectra launched in China

Early August 2018, NexGard Spectra (afoxolaner and milbemycin oxime), the first oral endectocide for dogs, was launched in China. Click here to learn more.
Supporting Fundappas

Supporting Fundappas

Fundappas is the first school of guide and assistance dogs in Uruguay. We support Fundappas to improve the quality of life of dogs and people. Learn more.
Harold Heart and Heart Failure

Harold Heart and Heart Failure

People with heart failure may experience a significant physical, social and emotional impact on their daily life. Click here to find out more information.
Living with heart failure

Living with heart failure

Click here to hear Patricia’s story on the impact that heart failure can have on mental health and the importance of finding support networks.
COVID-19: Research Update

COVID-19: Research Update

Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19. Learn more.
Empowering all employees

Empowering all employees

Boehringer Ingelheim has been awarded as a Global Top Employer for the second year in succession. Find out more about why we are a Global Top Employer.
Production Insights

Production Insights

Boehringer Ingelheim makes an important contribution to the reliable and sustainable supply of pharmaceuticals. Click here to learn and find out more.